88 results
Page 2 of 5
8-K
EX-1.1
4qk5e5p11si3thdc
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
S-3
EX-4.6
rxh5bv8p78o87rpj2vf
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.7
unw7d c4mux76rzer
1 Jul 22
Shelf registration
4:13pm
S-3
EX-1.2
vn5nye 6igp6rvwotw
1 Jul 22
Shelf registration
4:13pm
DEF 14A
rii83idmhp5
28 Apr 22
Definitive proxy
8:36am
424B3
tk5v5e70
31 Mar 22
Prospectus supplement
11:42am
POS AM
f6un02r4
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
EX-10.3
nq27y2hgh9724yyfludq
10 Dec 21
Prospectus supplement
8:24am
424B3
EX-10.1
qioph9ry8kpml36n sdn
10 Dec 21
Prospectus supplement
8:24am
424B3
EX-10.2
hasqtbig3ag23wziy5p
10 Dec 21
Prospectus supplement
8:24am
8-K
EX-10.3
ho9iny63l0g
10 Dec 21
Departure of Directors or Certain Officers
8:17am
8-K
EX-10.2
9eim1yhcd
10 Dec 21
Departure of Directors or Certain Officers
8:17am
8-K
EX-10.1
4sz5ifmj wx7c
10 Dec 21
Departure of Directors or Certain Officers
8:17am
424B3
flo5ewr
5 Aug 21
Prospectus supplement
4:26pm
8-K
jmxo59b njrkoqz
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.6
nt5i p24qje
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.5
hr8dsv yil1i7gmx8jd9
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am